Preservationists are pressing ahead with their lawsuit against President Donald Trump's planned $400 million White House ballroom, declining a request by the Department of Justice to withdraw the ...

Shockingly, Olivia Rodrigo does not want her ex to “drop dead.” The music video for the lead single off her upcoming album, You Seem Pretty Sad for a Girl So in Love, dropped today and despite the ...

Kanye West’s headlining spot at London’s Wireless Festival sparks controversy as Pepsi and Diageo, the parent company of Guinness and Smirnoff, pull their sponsorships. The move comes after West’s ...

Nike provided a disappointing sales outlook, and the quick harsh reaction in the stock market might be laying the groundwork for a lucrative long-term investment. Are you a contrarian investor? Then a ...

The 2026 baseball season begins this week, and for that we’re eternally grateful. Sure, it starts too early and ends too late, leading to cold-weather games every spring and World Series games into ...

The Carolina Panthers signed the best off-ball linebacker, the second-best edge rusher, the second-best left tackle, and a handful of other players in free agency last week. Given how much they spent, ...

“Citrus, Altius, Fortius — Communiter.” — the updated Olympic motto. In case your Latin is a bit rusty, the above motto translates to “Faster, Higher, Stronger — Together.” The original motto, adopted ...

Walmart's post-earnings on Thursday decline was short-lived, with analysts and investors betting the company is being overly conservative with its forward guidance. The stock fell as much as 3.6% in ...

Nvidia could face a high-expectations problem with its upcoming Q4 update. The GPU maker will also report its quarterly results in an environment of skepticism about the ROI for AI investments. If ...

Many Nvidia (NASDAQ: NVDA) investors have probably circled Feb. 25, 2026, on their calendars. That's the date the giant chipmaker is scheduled to announce its fiscal 2025 fourth-quarter results.

Shares of CSPC Pharmaceutical Group fell sharply after the Chinese company inked a multibillion-dollar deal with pharmaceutical giant AstraZeneca for its long-acting obesity drug. The Hong Kong-listed ...

You can probably remember at least one education choice you regret. You don’t have to be lazy or naive to pick the wrong subject, just lacking in information about what you will actually have to study ...